BTEE - iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (IE00BDZVHG35)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.

Sélectionnez tout Réinitialiser tout

Enregistrer Fermer

(%)

IE00BDZVHG35

BTEE ISIN

Fonds négociés en bourse (FNB)

Type de fonds

BlackRock

Fournisseur

9,93 USD

valeur liquidative par action | 07/07/2026

05/03/2018

Date de lancement

2 fois par an

Paiement de dividendes

CEOIES

CFI

BTEE

Ticker

Formed

Status

Equity

Objet d'investissement

Biotech

Secteur

USA

Géographie

Nasdaq Biotechnology Index(R)

Benchmark

0.35 %

Ratio de coût total

1.107,85 mln USD

Actif total du fonds | 06/07/2026

Oui

UCITS

Dernières données pour

Ajouter à comparer

Cotations (BTEE)

Explorer la base de données la plus complète

1 000 000

obligations

80 234

actions

175 910

ETF & Funds

80 000

indices

Suivre votre portefeuille de la manière la plus efficace

Screener d'obligations
liste de surveillance
Excel ADD-IN

Obtenir l'accès

Dynamique des prix

Fund profile

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEE profile

The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 05.03.2018 with unique ISIN - IE00BDZVHG35. Main exchange is London S.E. (USD) and ticker symbol is BTEE. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) pays dividends 2 time(s) per year.

Structure BTEE au 06/07/2026

Exporter la structure dans Excel

Titre	Valeur
VERTEX PHARMACEUTICALS INC	8,43%
AMGEN INC	7,75%
GILEAD SCIENCES INC	6,87%
REGENERON PHARMACEUTICALS INC	4,55%
ALNYLAM PHARMACEUTICALS INC	2,84%
REVOLUTION MEDICINES INC	2,74%
MODERNA INC	2,21%
BIOGEN INC	2,09%
ILLUMINA INC	2%
ROIVANT SCIENCES LTD	1,73%
ARGENX SE ADR	1,72%
ROYALTY PHARMA PLC CLASS A	1,71%
INSMED INC	1,64%
UNITED THERAPEUTICS CORP	1,58%
INCYTE CORP	1,57%
GUARDANT HEALTH INC	1,52%
VIATRIS INC	1,33%
NEUROCRINE BIOSCIENCES INC	1,19%
ASCENDIS PHARMA	1,12%
MEDPACE HOLDINGS INC	1,1%
JAZZ PHARMACEUTICALS PLC	1,04%
BRIDGEBIO PHARMA INC	1,04%
EXELIXIS INC	0,95%
IONIS PHARMACEUTICALS INC	0,94%
AXSOME THERAPEUTICS INC	0,85%
SUMMIT THERAPEUTICS INC	0,84%
MADRIGAL PHARMACEUTICALS INC	0,83%
ARROWHEAD PHARMACEUTICALS INC	0,83%
CYTOKINETICS INC	0,79%
BIOMARIN PHARMACEUTICAL INC	0,77%
KRYSTAL BIOTECH INC	0,75%
BIONTECH SE ADR	0,74%
TEMPUS AI INC CLASS A	0,72%
BEONE MEDICINES AG	0,69%
SANOFI ADR REPRESENTING SA	0,67%
HALOZYME THERAPEUTICS INC	0,65%
KYMERA THERAPEUTICS INC	0,64%
IMMUNITYBIO INC	0,63%
ALKERMES	0,62%
NUVALENT INC CLASS A	0,62%
PRAXIS PRECISION MEDICINES INC	0,59%
PROTAGONIST THERAPEUTICS INC	0,57%
APOGEE THERAPEUTICS INC	0,56%
ABIVAX AMERICAN DEPOSITARY SHARES	0,56%
VAXCYTE INC	0,56%
IMMUNOVANT INC	0,54%
SPYRE THERAPEUTICS INC	0,52%
RHYTHM PHARMACEUTICALS INC	0,52%
MIRUM PHARMACEUTICALS INC	0,5%
PTC THERAPEUTICS INC	0,48%
COGENT BIOSCIENCES INC	0,46%
SCHOLAR ROCK HOLDING CORP	0,45%
LIGAND PHARMACEUTICALS INC	0,43%
TWIST BIOSCIENCE CORP	0,42%
CG ONCOLOGY INC	0,41%
CRISPR THERAPEUTICS AG	0,4%
ERASCA INC	0,4%
XENON PHARMACEUTICALS INC	0,4%
AMNEAL PHARMACEUTICALS INC CLASS A	0,37%
TRAVERE THERAPEUTICS INC	0,36%
CARIS LIFE SCIENCES INC	0,34%
ORUKA THERAPEUTICS INC	0,34%
INDIVIOR PHARMACEUTICALS INC	0,33%
DEFINIUM THERAPEUTICS INC	0,33%
10X GENOMICS INC CLASS A	0,32%
VERACYTE INC	0,31%
CRINETICS PHARMACEUTICALS INC	0,3%
ACADIA PHARMACEUTICALS INC	0,3%
TANGO THERAPEUTICS INC	0,29%
EDGEWISE THERAPEUTICS INC	0,29%
STRUCTURE THERAPEUTICS ADR INC	0,29%
DENALI THERAPEUTICS INC	0,28%
NEWAMSTERDAM PHARMA NV	0,28%
RELAY THERAPEUTICS INC	0,27%
DYNE THERAPEUTICS INC	0,26%
BEAM THERAPEUTICS INC	0,25%
ADAPTIVE BIOTECHNOLOGIES CORP	0,24%
IDEAYA BIOSCIENCES INC	0,23%
ALUMIS INC	0,23%
ULTRAGENYX PHARMACEUTICAL INC	0,22%
ARCUTIS BIOTHERAPEUTICS INC	0,22%
ENLIVEN THERAPEUTICS INC	0,21%
GRAIL INC	0,2%
DISC MEDICINE INC	0,2%
KINIKSA PHARMACEUTICALS INTERNATIO	0,2%
TARSUS PHARMACEUTICALS INC	0,2%
VERA THERAPEUTICS INC CLASS A	0,19%
MBX BIOSCIENCES INC	0,19%
SUPERNUS PHARMACEUTICALS INC	0,19%
UNIQURE NV	0,18%
BIOCRYST PHARMACEUTICALS INC	0,18%
TREVI THERAPEUTICS INC	0,17%
NURIX THERAPEUTICS INC	0,17%
INTELLIA THERAPEUTICS INC	0,17%
MINERALYS THERAPEUTICS INC	0,16%
VERICEL CORP	0,16%
ABCELLERA BIOLOGICS INC	0,16%
KODIAK SCIENCES INC	0,16%
LEGEND BIOTECH ADR REP CORP	0,16%
PHARVARIS N V NV	0,16%

Montrer tout Cacher

Autres - %

Autres actions de ce fonds

iShares Nasdaq US Biotechnology UCITS ETF

Montrer tout

Autres ETF et fonds de ce fournisseur

ETF et fonds similaires

{{ item.etf.ttl }}

{{ item.nav_usd }} mln
Valeur nette d'actifs

{{ item.expense_ratio }}
Ratio de coût total